[{"data":1,"prerenderedAt":272},["ShallowReactive",2],{"story-5349-cn":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":48,"questions":49,"relatedArticles":59,"body_color":270,"card_color":271},"5349",null,"三星生物制药通过战略性美国扩张打破全球制药生产边界","通过定向跨境制造投资，变革国际医药供应链",[],[10,11,12,13,14,15,16,17,18,19,20,21,15,22,23,24,25,26,26,26,27,26,17,28,29,26,30,31,32,23,33,34,35,36,37,38,39,40,26,41,42,43,44,45,46,47],"https://commercialobserver.com/wp-content/uploads/sites/3/2025/12/John-Rim-HGSI-Samsung-Biologics-campus-Rockville-Md-credit-Samsung-Biologics.jpg?quality=80&w=763&h=489&crop=1","https://cdn.techinasia.com/wp-content/uploads/2025/06/1750134121_headquarters_itm1-750x419.jpg","https://image.ajunews.com/content/image/2025/12/22/20251222094433938159.jpg","https://www.biospectrumasia.com/uploads/articles/screenshot_22_12_2025_12138_www_prnewswire_com-27025.jpeg","https://www.koreabiomed.com/news/photo/202512/30050_32264_1016.jpg","https://cdn.zonebourse.com/static/resize/0/0//images/reuters/2025-04/2025-04-30T061040Z_1_LYNXMPEL3T07L_RTROPTP_4_GSK-RESULTS.JPG","https://koreajoongangdaily.joins.com/data/photo/2025/12/22/3da1e453-007e-4471-ae2a-0dd56ae6b89f.jpg","https://www.chosun.com/resizer/v2/MVTDMMTCGA4TOOJYGVRGKNJVHE.jpg?auth=c53c397423e1368d2bd9599b10640d6ff7e5b7ed0e9843acf424a64ebd6a715c&width=616","https://cdn.zonebourse.com/static/resize/1200/675//images/reuters/2024-10-09T081107Z_1_LYNXMPEK98083_RTROPTP_3_GERMANY.JPG","https://wimg.mk.co.kr/news/cms/202512/23/20251223_01110105000003_M00.jpg","https://www.globalbankingandfinance.com/_next/image/?url=https%3A%2F%2Fimagedelivery.net%2FMkQ8HKvpw9EqULcU_pSqWg%2Fcloud-bccb4c31-c889-45a7-ae13-69de0e2045aa%2Fpublic&w=3840&q=85&dpl=dpl_AW2uQ8ma8YWXu6MmDoKdviVr2XKJ","https://businessfacilities.com/wp-content/uploads/2025/12/samsung-biologics-gsk-md.jpg","https://newsimg.koreatimes.co.kr/2025/12/22/de376285-e78f-4d0b-9f63-c1bb9f1cbd57.jpg","https://wimg.heraldcorp.com/news/cms/2025/12/22/news-p.v1.20251222.ac0ef926fe1d4024bd06c43bf9aae125_P1.png","https://www.geneonline.com/wp-content/uploads/EN_Mobile_Dec_HIV_AIDS-450x350.png","https://bl-i.thgim.com/public/incoming/l6m6g2/article70424971.ece/alternates/LANDSCAPE_1200/f9c7e60d7c6e4e8e8507caae03a8eeef_thumb.jpg","https://mma.prnewswire.com/media/2850103/Image__Samsung_Biologics_Expands_U_S__Manufacturing_Capabilities.jpg","https://www.asiabusinessoutlook.com/uploaded_images/newstransfer/d7i01736220811_shutterstock_1668796654-scaled.jpg","https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1SN2cq.img?w=768&h=512&m=6","https://www.azernews.az/media/2025/12/22/samsung_biologics.jpg","https://cdn.bisnow.net/fit?height=1200&type=png&url=https%3A%2F%2Fs3.amazonaws.com%2Fcdn.bisnow.net%2Fcontent%2Fimages%2F2025%2F12%2F69495ffa1d4ba-screenshot-2025-12-22-at-10-12-06-am.png&width=1200&sign=WbFuNxaEu_VAnVSDoyLPlGnrcmoBTZOIrtF9jbW4fbQ","https://wimg.mk.co.kr/news/cms/202512/22/news-p.v1.20251222.57dd4c90002044bd87368891bf9bcb2e_P1.jpg","https://etimg.etb2bimg.com/photo/126113611.cms","https://cdn4.premiumread.com/?url=https://www.manilatimes.net/theme_manilatimes/images/TMT_1920x1008.jpg&w=1200&q=100&f=webp&t=1","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-2215021361.jpg?VersionId=UngKaoH_bkUnG.FBzEAB0.I9J9Tbdqj9","https://www.indianpharmapost.com/public/thumbs/news/2025/12/18647/Human_Genome_Sciences1.jpg","https://www.contractpharma.com/wp-content/uploads/sites/6/2025/12/human-genome-sciences.jpg","https://wimg.mk.co.kr/news/cms/202512/22/news-p.v1.20251222.439cb83c6cfa4c8cbd276b97b3b33b51_P1.jpg","https://unn.ua/_next/image?url=https%3A%2F%2Funn.ua%2Fimg%2F2025%2F12%2F22%2F1766362912-1073-large.webp&w=720&q=75","https://etimg.etb2bimg.com/thumb/msid-126112253,width-1200,height-900,resizemode-4/.jpg","https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1SN8Zv.img?w=768&h=576&m=6","https://biz.chosun.com/resizer/v2/LNKJ7S73BFAHHGXFOUY34V7MVU.jpg?auth=a73c11558caf24315412a05b15d5e805285a246762d49095380da17e57b1a8f0&width=1200&height=630&smart=true","https://media.bizj.us/view/img/13113056/imagesamsungbiologicsexpandsusmanufacturingcapabilities*900xx2161-1218-0-0.jpg","http://koreabizwire.com/wp/wp-content/uploads/2025/01/AEN20250114002800320_01_i_org.jpg","https://www.reuters.com/resizer/v2/OPPP273TMJKEFBIK4LWZSRVDUA.jpg?auth=f3ee02bcc19483ffdf09c5351693428ccf1859c3e5360433c0d23a659c148aa9&width=1920&quality=80","https://m.economictimes.com/thumb/msid-126112281,width-1200,height-900,resizemode-4,imgsize-23350/samsung-biologics-to-invest-usd-4-8-billion-in-new-songdo-bio-campus.jpg","https://cdn.sanity.io/images/0vv8moc6/pharma_commerce/3a9baad4cf5d395b09197012b1369b904b38f795-1592x886.png?w=1592&max-h=886&fit=crop&auto=format","https://images.ft.com/v3/image/raw/https%3A%2F%2Fcms-image-bucket-productionv3-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F3%2F8%2F2%2F8%2F11858283-2-eng-GB%2Fa9ad3878cab7-2025-12-17T000129Z_372490497_RC2AYCAK1RN4_RTRMADP_3_HEALTH-USA-GSK-2-.JPG?width=780&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto","**三星生物制药** 通过一项大胆的 2.8 亿美元的战略收购，正在改写国际制药生产的规则手册，从而改变其全球生产能力。通过收购葛兰素史克位于马里兰州罗克维尔的工厂，该公司正在执行一项复杂的市场进入战略，这远不止简单的资产收购。\n\n此次收购不仅仅是一笔交易——而是一场经过精心策划的地缘政治和经济策略。**三星生物制药** 正在建立一个连接韩国松岛和美国罗克维尔的双半球生产系统，该系统在战略上降低了区域供应链风险，同时为北美客户提供了本地生产的选择。鉴于当前药品本土化和潜在贸易政策转变的背景，此举尤为精明。\n\n**60,000 升药物生产设施** 具有关键优势：500 名现有工人，他们确保了即时生产的连续性和深入的机构知识转移。通过保留整个劳动力，三星生物制药表明，成功的国际扩张不仅仅是基础设施，还关乎人力资本和专业知识，对此有着细致入微的理解。\n\n至关重要的是，这项投资与强调国内制药生产的更广泛的美国政策趋势相一致。根据现有的贸易协定，对韩国药品进口到美国的关税上限为 15%，而仿制药则免征关税——这为这一战略举措创造了有利的环境。该公司目前在韩国的 5 个工厂拥有 785,000 升的产能，这使得美国的这家工厂成为互补而非冗余的扩张。\n\n此次收购标志着一种成熟的全球市场定位方法。三星生物制药不仅仅是在购买一个设施；它正在具有竞争力的美国制药生产领域建立一个桥头堡。通过投资现有基础设施，该公司可以快速扩大产能，而无需耗时的从头开始建设过程。\n\n对于制药公司和投资者来说，这代表了战略性国际扩张的典范——利用现有资产，保持劳动力连续性，并为未来的市场动态做好准备。",[50,53,56],{"title":51,"answer":52,"author":5,"avatar":5,"time":5},"三星生物为什么要在美国制造工厂投资 2.8 亿美元？","三星生物制品公司正通过建立美国生产基地来战略性地扩大其全球制造版图。此举旨在降低供应链风险，为北美客户提供本地化生产选择，并可能受益于支持国内制药生产的美国政策。",{"title":54,"answer":55,"author":5,"avatar":5,"time":5},"这次收购为三星生物制药带来了哪些竞争优势？","此次收购带来了多重优势：即刻拥有6万升的生产能力，保留了500名经验丰富的员工，潜在的关税优惠，以及位于关键生物技术集群的战略位置。此外，它还无需从头开始建设设施，就能快速进入市场。",{"title":57,"answer":58,"author":5,"avatar":5,"time":5},"这项收购如何融入三星生物制剂更广泛的全球战略？","这标志着三星生物制剂全球扩张战略的关键一步，构建连接韩国和美国的双半球生产体系。它展现了公司致力于成为一家主要的国际合同生产组织 (CMO) 的决心，拥有灵活、高质量的药品生产能力。",[60,65,70,74,78,82,86,90,94,98,101,105,109,112,116,120,123,127,131,135,138,141,145,148,152,156,160,163,167,171,175,179,183,187,190,194,198,201,204,207,211,215,219,223,227,231,234,238,242,245,249,252,256,259,262,266],{"id":61,"title":62,"source":63,"logo":44,"time":64},129682,"Samsung Biologics to buy US drug production facility from GSK for $280 million","https://www.reuters.com/business/healthcare-pharmaceuticals/samsung-biologics-buy-us-drug-production-facility-gsk-280-mln-2025-12-21/","3天前",{"id":66,"title":67,"source":68,"logo":30,"time":69},132212,"Samsung Biologics To Pay $280M For Maryland Manufacturing Campus","https://www.bisnow.com/washington-dc/news/life-sciences/samsung-biologics-pays-280m-for-montgomery-county-manufacturing-campus-132479","2天前",{"id":71,"title":72,"source":73,"logo":31,"time":64},129683,"Samsung Biologics has taken over the U.S. biopharmaceutical production facility of global pharmaceut..","https://www.mk.co.kr/en/it/11497617",{"id":75,"title":76,"source":77,"logo":46,"time":69},132211,"Samsung Biologics Enters US Manufacturing Market with $280M GSK Site Acquisition","https://www.pharmaceuticalcommerce.com/view/samsung-biologics-enters-us-manufacturing-market-gsk-site-acquisition",{"id":79,"title":80,"source":81,"logo":5,"time":64},129684,"Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK","https://www.prnewswire.com/news-releases/samsung-biologics-expands-us-manufacturing-capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk-302647637.html",{"id":83,"title":84,"source":85,"logo":10,"time":69},132210,"Samsung Biologics to Acquire First U.S. Drug Manufacturing Facility in $280M Deal","https://commercialobserver.com/2025/12/samsung-biologics-maryland-life-sciences/",{"id":87,"title":88,"source":89,"logo":14,"time":64},129600,"Samsung Biologics secures 1st US manufacturing base with GSK facility acquisition","https://www.koreabiomed.com/news/articleView.html?idxno=30050",{"id":91,"title":92,"source":93,"logo":35,"time":64},132214,"Samsung Biologics strengthens U.S. presence with acquisition of GSK’s Human Genome Sciences or $280 million","https://www.indianpharmapost.com/biopharma/samsung-biologics-strengthens-us-presence-with-acquisition-of-gsks-human-genome-sciences-or-280-million-18647",{"id":95,"title":96,"source":97,"logo":17,"time":64},129601,"Samsung Biologics Acquires GSK's U.S. Facility, First Production Base","https://www.chosun.com/english/industry-en/2025/12/22/KQ3YOEEQLZB27KW46B4EYRILDA/",{"id":99,"title":62,"source":100,"logo":33,"time":69},132213,"https://www.manilatimes.net/2025/12/23/business/foreign-business/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/2248220",{"id":102,"title":103,"source":104,"logo":22,"time":64},129681,"Samsung Biologics takes over bio plant in Maryland from GSK","https://www.koreatimes.co.kr/business/tech-science/20251222/samsung-biologics-takes-over-bio-plant-in-maryland-from-gsk",{"id":106,"title":107,"source":108,"logo":11,"time":64},129594,"Samsung Biologics to buy US drug plant from GSK for $280m","https://www.techinasia.com/news/samsung-biologics-buy-us-drug-plant-gsk-280m",{"id":110,"title":62,"source":111,"logo":45,"time":64},129595,"https://m.economictimes.com/news/international/business/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/articleshow/126112276.cms",{"id":113,"title":114,"source":115,"logo":39,"time":64},129596,"Samsung Biologics to buy its first US drug production facility from GSK for $280 million","https://pharma.economictimes.indiatimes.com/news/pharma-industry/samsung-biologics-to-buy-its-first-us-drug-production-facility-from-gsk-for-280-million/126112253",{"id":117,"title":118,"source":119,"logo":5,"time":64},129597,"Samsung Biologics acquires Human Genome Sciences from GSK","https://www.tipranks.com/news/the-fly/samsung-biologics-acquires-human-genome-sciences-from-gsk-thefly",{"id":121,"title":80,"source":122,"logo":26,"time":64},129598,"https://themalaysianreserve.com/2025/12/22/samsung-biologics-expands-u-s-manufacturing-capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk/",{"id":124,"title":125,"source":126,"logo":26,"time":64},129599,"Samsung Biologics Expands U.S. Manufacturing Capabilities with S","https://www.gurufocus.com/news/4079138/samsung-biologics-expands-us-manufacturing-capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk",{"id":128,"title":129,"source":130,"logo":43,"time":64},129590,"Samsung Biologics to Buy GSK Manufacturing Facility in U.S. for $280 Million","http://koreabizwire.com/samsung-biologics-to-buy-gsk-manufacturing-facility-in-u-s-for-280-million/340629",{"id":132,"title":133,"source":134,"logo":27,"time":64},129591,"Samsung Biologics to Acquire GSK's Maryland Plant for $280M","https://www.asiabusinessoutlook.com/news/samsung-biologics-to-acquire-gsk-s-maryland-plant-for-280m-nwid-10922.html",{"id":136,"title":62,"source":137,"logo":32,"time":64},129592,"https://manufacturing.economictimes.indiatimes.com/news/life-sciences/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/126113585",{"id":139,"title":62,"source":140,"logo":40,"time":64},129593,"https://www.msn.com/en-in/money/topstories/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/ar-AA1SNhV3?ocid=finance-verthp-feeds",{"id":142,"title":143,"source":144,"logo":34,"time":64},130809,"Samsung Biologics pays GSK $280M to secure first US manufacturing site","https://www.fiercepharma.com/manufacturing/samsung-biologics-pays-gsk-280m-secure-first-us-manufacturing-site",{"id":146,"title":114,"source":147,"logo":20,"time":64},129583,"https://www.globalbankingandfinance.com/samsung-biologics-usa/",{"id":149,"title":150,"source":151,"logo":23,"time":64},129584,"Samsung Biologics acquires $280m GSK plant, securing first US manufacturing base","https://www.theinvestor.co.kr/article/10641706",{"id":153,"title":154,"source":155,"logo":5,"time":64},129585,"Samsung Biologics Stock: Slips Nearly 5% After $280M GSK Maryland Plant Acquisition","https://coincentral.com/samsung-biologics-stock-slips-nearly-5-after-280m-gsk-maryland-plant-acquisition/",{"id":157,"title":158,"source":159,"logo":13,"time":64},129586,"Korea's Samsung Biologics expands US manufacturing capabilities after acquiring Human Genome Sciences from GSK","https://www.biospectrumasia.com/news/28/27025/koreas-samsung-biologics-expands-us-manufacturing-capabilities-after-acquiring-human-genome-sciences-from-gsk.html",{"id":161,"title":62,"source":162,"logo":25,"time":64},129587,"https://www.thehindubusinessline.com/companies/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/article70424941.ece",{"id":164,"title":165,"source":166,"logo":5,"time":64},129588,"Samsung Biologics Unit to Acquire GSK's Human Genome Sciences Facility in US for $280 Million","https://www.marketscreener.com/news/samsung-biologics-unit-to-acquire-gsk-s-human-genome-sciences-facility-in-us-for-280-million-ce7d50d2da8cfe24",{"id":168,"title":169,"source":170,"logo":16,"time":64},129589,"Samsung Biologics to acquire U.S. drug manufacturing facility from GSK","https://koreajoongangdaily.joins.com/news/2025-12-22/business/industry/Samsung-Biologics-to-acquire-US-drug-manufacturing-facility-from-GSK/2483446",{"id":172,"title":173,"source":174,"logo":5,"time":64},130778,"GSK to Sell US Manufacturing Site to Samsung Biologics for $280 Million","https://www.marketscreener.com/news/gsk-to-sell-us-manufacturing-site-to-samsung-biologics-for-280-million-ce7d50d2df8ef62c",{"id":176,"title":177,"source":178,"logo":37,"time":64},130779,"Samsung Biologics has secured a production base in North America by acquiring the U.S. biopharmaceut..","https://www.mk.co.kr/en/it/11504576",{"id":180,"title":181,"source":182,"logo":38,"time":64},129580,"Samsung Biologics acquires its first US plant for $280 million","https://unn.ua/en/news/samsung-biologics-acquires-its-first-us-plant-for-dollar280-million",{"id":184,"title":185,"source":186,"logo":18,"time":64},129581,"GSK to Sell Human Genome Sciences Unit to Samsung Biologics for $280 Million","https://www.marketscreener.com/news/gsk-to-sell-human-genome-sciences-unit-to-samsung-biologics-for-280-million-ce7d50d2df88fe27",{"id":188,"title":177,"source":189,"logo":19,"time":64},129582,"https://www.mk.co.kr/en/it/11504495",{"id":191,"title":192,"source":193,"logo":29,"time":69},130781,"Samsung Biologics to acquire GSK’s US plant","https://www.azernews.az/region/251990.html",{"id":195,"title":196,"source":197,"logo":17,"time":69},130782,"Samsung Biologics Acquires GlaxoSmithKline's U.S. Biopharmaceutical Facility","https://www.chosun.com/english/industry-en/2025/12/23/NSIRQV3NKZAE3IRMSPVDUDHFYE/",{"id":199,"title":150,"source":200,"logo":23,"time":64},130780,"https://www.koreaherald.com/article/10641494",{"id":202,"title":62,"source":203,"logo":5,"time":64},130785,"https://www.pharmalive.com/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/",{"id":205,"title":62,"source":206,"logo":15,"time":64},130786,"https://www.marketscreener.com/news/samsung-biologics-to-buy-its-first-us-drug-production-facility-from-gsk-for-280-million-ce7d50d2db8df322",{"id":208,"title":209,"source":210,"logo":12,"time":64},129578,"Samsung Biologics acquires GSK biopharmaceutical plant in U.S. for $280 million","https://www.ajupress.com/view/20251222093600641",{"id":212,"title":213,"source":214,"logo":47,"time":64},130783,"Samsung Biologics to buy GSK drug plant in US for $280m","https://asia.nikkei.com/business/business-deals/samsung-biologics-to-buy-gsk-drug-plant-in-us-for-280m",{"id":216,"title":217,"source":218,"logo":5,"time":64},129579,"Samsung Biologics acquires first U.S.-based manufacturing facility","https://en.yna.co.kr/view/AEN20251222002500320",{"id":220,"title":221,"source":222,"logo":36,"time":64},130784,"Samsung Biologics Acquires Human Genome Sciences from GSK","https://www.contractpharma.com/breaking-news/samsung-biologics-acquires-human-genome-sciences-from-gsk/",{"id":224,"title":225,"source":226,"logo":24,"time":69},132209,"Samsung Biologics Acquires $280 Million Manufacturing Facility in Maryland from GSK","https://www.geneonline.com/samsung-biologics-acquires-280-million-manufacturing-facility-in-maryland-from-gsk/",{"id":228,"title":229,"source":230,"logo":21,"time":69},132208,"Samsung Biologics Pays $280M For U.S. Drug Manufacturing Facility| Biotech","https://businessfacilities.com/samsung-biologics-pays-280m-maryland-drug-manufacturing-facility",{"id":232,"title":80,"source":233,"logo":26,"time":64},130787,"https://www.streetinsider.com/PRNewswire/Samsung+Biologics+Expands+U.S.+Manufacturing+Capabilities+with+Strategic+Acquisition+of+Human+Genome+Sciences+from+GSK/25766508.html",{"id":235,"title":236,"source":237,"logo":5,"time":69},132207,"News | Samsung Biologics to acquire facility outside DC for first US manufacturing plant","https://www.costar.com/article/2043707008/samsung-biologics-to-acquire-facility-outside-dc-for-first-us-manufacturing-plant",{"id":239,"title":240,"source":241,"logo":41,"time":64},129602,"Samsung Biologics acquires Rockville plant to secure US manufacturing base - CHOSUNBIZ","https://biz.chosun.com/en/en-science/2025/12/22/ORU4DPSYPBB37DX7RANLGIRT3A/",{"id":243,"title":62,"source":244,"logo":28,"time":64},129603,"https://www.msn.com/en-us/money/companies/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/ar-AA1SMM0P?ocid=finance-verthp-feeds",{"id":246,"title":247,"source":248,"logo":15,"time":64},129604,"Samsung Biologics to buy U.S. drug production facility from GSK for $280 million","https://www.marketscreener.com/news/samsung-biologics-to-buy-u-s-drug-production-facility-from-gsk-for-280-mln-ce7d50d2db8df722",{"id":250,"title":80,"source":251,"logo":26,"time":64},129605,"https://www.lelezard.com/en/news-22060311.html",{"id":253,"title":254,"source":255,"logo":5,"time":64},129606,"Samsung Biologics snaps up Maryland drug plant, its first in the US","https://www.stocktitan.net/news/GSK/samsung-biologics-expands-u-s-manufacturing-capabilities-with-58iknggvxlzv.html",{"id":257,"title":80,"source":258,"logo":26,"time":64},129607,"https://www.barchart.com/story/news/36736421/samsung-biologics-expands-u-s-manufacturing-capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk",{"id":260,"title":80,"source":261,"logo":5,"time":64},129608,"https://finance.yahoo.com/news/samsung-biologics-expands-u-manufacturing-224300355.html",{"id":263,"title":264,"source":265,"logo":26,"time":64},129609,"Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK – Company Announcement - FT.com","https://markets.ft.com/data/announce/detail?dockey=600-202512211743PR_NEWS_USPRX____CN52272-1",{"id":267,"title":268,"source":269,"logo":42,"time":64},132370,"Samsung Biologics to acquire GSK's Rockville campus for $280M in first US manufacturing move","https://www.bizjournals.com/washington/news/2025/12/22/samsung-biologics-gsk-acquisition-rockville.html","#070d29ff","#070d294d",1766645469699]